Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Amgen
National Cancer Institute (NCI)
Amgen
Deciphera Pharmaceuticals, LLC
City of Hope Medical Center
Amgen
Amgen
Amgen
Memorial Sloan Kettering Cancer Center
Vividion Therapeutics, Inc.
Amgen
Gruppo Oncologico del Nord-Ovest
Amgen
M.D. Anderson Cancer Center
Amgen
Memorial Sloan Kettering Cancer Center
Hoffmann-La Roche
Verastem, Inc.
Revolution Medicines, Inc.
NYU Langone Health
Medical University of South Carolina
SWOG Cancer Research Network
Amgen
Amgen
M.D. Anderson Cancer Center
Federation Francophone de Cancerologie Digestive
Memorial Sloan Kettering Cancer Center
Gustave Roussy, Cancer Campus, Grand Paris
Vitrac Therapeutics, LLC
Allist Pharmaceuticals, Inc.
Fundación GECP
Ningbo Newbay Technology Development Co., Ltd
Navire Pharma Inc., a BridgeBio company
ETOP IBCSG Partners Foundation
Effector Therapeutics
Radboud University Medical Center
NYU Langone Health
Karolinska University Hospital
Vestre Viken Hospital Trust
Criterium, Inc.
Korea University Anam Hospital
Amgen
Erasca, Inc.
Fox Chase Cancer Center
Hoosier Cancer Research Network
Yonsei University